Woodline Partners LP Hille Vax, Inc. Transaction History

Woodline Partners LP

  • $11 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$11.86 - $15.93 $71,598 - $96,169
6,037 Added 31.79%
25,027 $361,000
Q1 2024

May 15, 2024
BUY
$14.15 - $19.75 $268,708 - $375,052
18,990 New
18,990 $315,000
Q3 2022

Nov 14, 2022
BUY
$10.5 - $22.01 $211,134 - $442,577
20,108 New
20,108 $344,000

Others Institutions Holding HLVX

# of Institutions
78
Shares Held
36.3M
Call Options Held
0
Put Options Held
0
View Full List

About HilleVax, Inc.

HLVX Quotes by TradingView
  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $65.2M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email